These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9165631)

  • 1. Enhanced neurobehavioral effects of cocaine with chronic neuroleptic exposure in rats.
    Kosten TA
    Schizophr Bull; 1997; 23(2):203-13. PubMed ID: 9165631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbamazepine reduces dopamine-mediated behavior in chronic neuroleptic-treated and untreated rats: implications for treatment of tardive dyskinesia and hyperdopaminergic states.
    LaHoste GJ; Wigal T; King BH; Schuck SEB; Crinella FM; Swanson JM
    Exp Clin Psychopharmacol; 2000 Feb; 8(1):125-132. PubMed ID: 10743913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective action of an atypical neuroleptic on the mechanisms related to the development of cocaine addiction: a pre-clinical behavioural study.
    Marinho EA; Oliveira-Lima AJ; Wuo-Silva R; Santos R; Baldaia MA; Hollais AW; Longo BM; Berro LF; Frussa-Filho R
    Int J Neuropsychopharmacol; 2014 Apr; 17(4):613-23. PubMed ID: 24345415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haloperidol (but not ziprasidone) withdrawal potentiates sensitization to the hyperlocomotor effect of cocaine in mice.
    Fukushiro DF; Carvalho Rde C; Ricardo VP; Alvarez Jdo N; Ribeiro LT; Frussa-Filho R
    Brain Res Bull; 2008 Sep; 77(2-3):124-8. PubMed ID: 18721669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dopamine sensitivity of brain-induced behavior after repeated administration of dopamine agonists and antagonists].
    Westermann KH; Schmidt J
    Biomed Biochim Acta; 1984; 43(7):1027-32. PubMed ID: 6517885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cocaine-induced locomotor activity and cocaine discrimination in dopamine D2 receptor mutant mice.
    Chausmer AL; Elmer GI; Rubinstein M; Low MJ; Grandy DK; Katz JL
    Psychopharmacology (Berl); 2002 Aug; 163(1):54-61. PubMed ID: 12185400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of dopamine supersensitivity in rats after chronic administration of blonanserin: Comparison with haloperidol.
    Hashimoto T; Baba S; Ikeda H; Oda Y; Hashimoto K; Shimizu I
    Eur J Pharmacol; 2018 Jul; 830():26-32. PubMed ID: 29684390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term haloperidol administration enhances and short-term administration attenuates the behavioral effects of cocaine in a place conditioning procedure.
    Kosten TA; DeCaprio JL; Nestler EJ
    Psychopharmacology (Berl); 1996 Dec; 128(3):304-12. PubMed ID: 8972550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double dissociation of the effects of haloperidol and the dopamine D3 receptor antagonist ABT-127 on acquisition vs. expression of cocaine-conditioned activity in rats.
    Banasikowski TJ; Bespalov A; Drescher K; Behl B; Unger L; Haupt A; Schoemaker H; Sullivan JP; Gross G; Beninger RJ
    J Pharmacol Exp Ther; 2010 Nov; 335(2):506-15. PubMed ID: 20724485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central serotonin(2B) receptor blockade inhibits cocaine-induced hyperlocomotion independently of changes of subcortical dopamine outflow.
    Devroye C; Cathala A; Di Marco B; Caraci F; Drago F; Piazza PV; Spampinato U
    Neuropharmacology; 2015 Oct; 97():329-37. PubMed ID: 26116760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of behavioral and neurochemical effects of cocaine by haloperidol.
    Bhattacharyya AK; Aulakh CS; Pradhan S; Ghosh P; Pradhan SN
    Arch Int Pharmacodyn Ther; 1979 Mar; 238(1):71-80. PubMed ID: 39530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cocaine-induced locomotor activity and cocaine discrimination in dopamine D4 receptor mutant mice.
    Katz JL; Chausmer AL; Elmer GI; Rubinstein M; Low MJ; Grandy DK
    Psychopharmacology (Berl); 2003 Oct; 170(1):108-14. PubMed ID: 12783155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haloperidol- and SCH23390-induced dopaminergic supersensitivities are not additive in the rat.
    Parashos SA; Barone P; Marin CA; Paraschos AJ; Kapitzoglou-Logothetis V; Chase TN
    Psychopharmacology (Berl); 1989; 98(2):189-92. PubMed ID: 2569216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum.
    Navailles S; De Deurwaerdère P; Porras G; Spampinato U
    Neuropsychopharmacology; 2004 Feb; 29(2):319-26. PubMed ID: 14560323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the discriminative stimulus effects of the D3 dopamine antagonist PNU-99194A in rats: comparison with psychomotor stimulants.
    Baker LE; Miller ME; Svensson KA
    Behav Pharmacol; 1997 Jun; 8(2-3):243-52. PubMed ID: 9833019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptic treatment for a substantial proportion of adult life: behavioural sequelae of 9 months haloperidol administration.
    Waddington JL; Gamble SJ
    Eur J Pharmacol; 1980 Oct; 67(4):363-9. PubMed ID: 7192633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between chronic haloperidol treatment and cocaine in rats: an animal model of intermittent cocaine use in neuroleptic treated populations.
    LeDuc PA; Mittleman G
    Psychopharmacology (Berl); 1993; 110(4):427-36. PubMed ID: 7870913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is dopamine antagonism a requisite of neuroleptic activity?
    Greenblatt EN; Coupet J; Rauh E; Szucs-Myers VA
    Arch Int Pharmacodyn Ther; 1980 Nov; 248(1):105-19. PubMed ID: 6111298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.